What people think about global access to COVID-19 treatments and vaccines

Listing image
Graphic showing two men wearing masks and a pill
File size
149028 bytes
Image width
512px
Image height
288px
Filename
coronavirus-treatments-and-vaccines-promo.jpg
Image
Graphic showing two men wearing masks and a pill
Download allowed
On
Listing summary

[Summary] Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus treatments and vaccines are first made available to those who need them most.

Priority areas
Coronavirus (Covid-19)
English
Topics
Coronavirus (Covid-19)
Epidemics
Standfirst

Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus (COVID-19) treatments and vaccines are first made available to those who need them most.

Content
Group
Link
Download the data
Link style
Primary
Content
Body
  • perspectives on global access to COVID-19 treatments and vaccines, based on a YouGov poll, commissioned by Wellcome, of more than 6,000 adults in the UK, the USA, Germany and France.
Body
  • policy makers
  • funders
  • global health advocates
Group title
Key findings
Group
  • The public in all four countries support the idea that coronavirus treatments and vaccines should first be provided for those who need them most in the world, not for those who can afford to buy them.
  • Between half and two-thirds of the public in each country support the idea that if a coronavirus treatment or vaccine is developed in their own country it should be made available around the world as quickly as possible, even if that means some people in their own country don't get it first.
  • An overwhelming majority of the public in all four countries believe that national governments should work together to ensure that coronavirus treatments and vaccines can be manufactured in as many countries as possible and distributed globally to everyone who needs them. 
  • More than two-thirds of the public in each country think that national governments shouldn't use coronavirus treatments and vaccines to gain an upper-hand in trade or diplomatic negotiations. 
Group title
Charts
Group
Gallery images
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those who need them most in the world
File size
275778 bytes
Image width
1024px
Image height
1292px
Filename
coronavirus-treatments-and-vaccines-should-first-be-provided-for-those-who-need-them-most-in-the-world.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those who need them most in the world
Download allowed
On
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those around the world who can afford to buy them
File size
285587 bytes
Image width
1024px
Image height
1292px
Filename
coronavirus-treatments-and-vaccines-should-first-be-provided-for-those-around-the-world-who-can-afford-to-buy-them.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those around the world who can afford to buy them
Download allowed
On
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those who live in the country in which they are first developed
File size
299224 bytes
Image width
1024px
Image height
1292px
Filename
coronavirus-treatments-and-vaccines-should-first-be-provided-for-those-who-live-in-the-country-in-which-they-are-first-developed.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on whether coronavirus treatments and vaccines should first be provided for those who live in the country in which they are first developed
Download allowed
On
Chart showing views of the public in the UK, the USA, Germany and France on how quickly a coronavirus vaccine or treatment should be made available around the world, even if developed in their country
File size
341379 bytes
Image width
1024px
Image height
1292px
Filename
if-coronavirus-treatment-or-vaccine-is-developed-in-your-country-it-should-be-made-available-around-the-world-as-quickly-as-possible.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on how quickly a coronavirus vaccine or treatment should be made available around the world, even if developed in their country
Download allowed
On
Chart showing views of the public in the UK, the USA, Germany and France on whether national governments should work together to ensure that coronavirus treatments and vaccines can be manufactured and distributed
File size
342793 bytes
Image width
1024px
Image height
1292px
Filename
national-governments-should-work-together-to-make-sure-that-coronavirus-treatments-and-vaccines-can-be-manufactured-and-distributed.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on whether national governments should work together to ensure that coronavirus treatments and vaccines can be manufactured and distributed
Download allowed
On
Chart showing views of the public in the UK, the USA, Germany and France on whether national governments should use a coronavirus treatment or vaccine to gain an upper-hand
File size
295761 bytes
Image width
1024px
Image height
1292px
Filename
national-governments-should-not-use-a-coronavirus-treatment-or-vaccine-to-gain-an-upper-hand-in-international-trade-or-diplomatic-negotiations.jpg
Image
Chart showing views of the public in the UK, the USA, Germany and France on whether national governments should use a coronavirus treatment or vaccine to gain an upper-hand
Download allowed
On
Create hero image
Off
Infographics gallery
Off

All figures, unless otherwise stated, are from YouGov Plc. The total sample size was 6,485 adults. Fieldwork was undertaken between 13-21 May 2020. The surveys were carried out online. The figures for each survey have been weighted and are representative of all [country] adults (aged 18+).

Group title
Downloads
Admin title
Data download - COVID-19
Group
Admin title
Data download - COVID-19
Listing layout
Link List
Content
Linked file
Admin title
Data download - COVID-19
Group title
Related content
Group
Listing layout
Image card with CTA link (Horizontal card)
Content
Body
All R&D funders, developers and manufacturers must help ensure that new vaccines, diagnostics and treatments developed for COVID-19 are globally available, appropriate and affordable, regardless of where they have been developed or who has funded them.
Title
Equitable access to vaccines, diagnostics and treatments for coronavirus (COVID-19)
Link
/what-we-do/our-work/coronavirus-covid-19/access
Published date
Modified date
Image
A woman wearing a face mask on the street in Alexandra, South Africa.
Credit
Gallo Images / Getty Images
File size
485093 bytes
Image width
1500px
Image height
844px
Filename
equitable-access-vaccines-diagnostics-treatments.jpg
Image
A woman wearing a face mask on the street in Alexandra, South Africa.
Download allowed
On
Body
We’ve awarded £12 million, in partnership with DFID, to speed up global COVID-19 research and development and help low- and middle-income countries prepare. But more investment is needed.
Title
Greater investment is needed to help countries with the weakest health systems prepare for COVID-19
Link
/news/greater-investment-needed-help-countries-weakest-health-systems-prepare-covid-19
Content type
Opinion
Published date
Modified date
Author
Christiane Hertz-Fowler and Georgia Walton
Image
Five parishoners in Malawi wash their hands as a preventive measure against the spread of COVID-19
Credit
Amos Gumulira / AFP / Getty Images
Caption

Parishoners in Malawi wash their hands as a preventive measure against the spread of Covid-19.

File size
1583484 bytes
Image width
1200px
Image height
675px
Filename
greater-investment-needed-to-help-countries-with-weakest-health-systems-prepare-for-covid-19-150420-1200.png
Image
Five parishoners in Malawi wash their hands as a preventive measure against the spread of COVID-19
Download allowed
On
Body
We want to help the world overcome Covid-19. Research is the best way to save lives – but more investment in accessible treatments, tests and vaccines is urgently needed to change the course of the pandemic.
Title
Coronavirus (Covid-19): supporting global research and development
Link
/what-we-do/our-work/coronavirus-covid-19
Published date
Modified date
Image
A map of the world, a hand holding a test tube and three children washing their hands
File size
866480 bytes
Image width
3333px
Image height
1204px
Filename
coronavirus-covid-19-supporting-global-research-and-development-1600px_0.jpg
Image
A map of the world, a hand holding a test tube and three children washing their hands
Download allowed
On
Meta title
What people think about global access to COVID-19 treatments and vaccines | Report | Wellcome
Published on
Meta description
Our polling of more than 5,000 adults in the UK, the USA and Germany, shows strong public support for making sure that any new coronavirus (COVID-19) treatments and vaccines are first made available to those who need them most.
Last updated date
Display in page navigation
On
Banner styling
Banner with image above title
Exclude from listings
Off
Banner image
what-people-think-about-global-access-to-covid-19-vaccines-and-treatments.jpg